Showing results (271-280 of 661) with videos related to

Sort By:
Pageof 67
Investigational New Drugs|March 5, 2013
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancerJoanne Brady, Pippa Corrie, Ian Chau, et al.
BMC Cancer|April 10, 2024
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 studyElena Elez, Antonio Cubillo, Pilar Garcia Alfonso, et al.
BMC Cancer|July 10, 2008
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparisonAsma Sultana, Paula Ghaneh, David Cunningham, et al.
British Journal of Haematology|October 7, 2009
IRF4 polymorphism rs872071 and risk of Hodgkin lymphomaPeter Broderick, David Cunningham, Jayaram Vijayakrishnan, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II studyVedang Murthy, Karen Thomas, Kerwyn Foo, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2010
Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse riskDavid Cunningham Owens, Eve C Johnstone, Patrick Miller, et al.
Annals of Surgery|March 22, 2017
Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term PrognosisSheraz R Markar, Hugh Mackenzie, Sara Jemal, et al.
The Lancet. Oncology|July 7, 2007
Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancerBrian D P O'Neill, Gina Brown, R J Heald, et al.
Human Molecular Genetics|November 3, 2009
Significant contributions of the extraembryonic membranes and maternal genotype to the placental pathology in heterozygous Nsdhl deficient female embryosDavid Cunningham, Tiffany Talabere, Natalie Bir, et al.
Medical Oncology (Northwood, London, England)|September 15, 2014
Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factorKyriakos Neofytou, Elizabeth C Smyth, Alexandros Giakoustidis, et al.
Pageof 67